TVRD
Tvardi Therapeutics
TVRD
TVRD
164 hedge funds and large institutions have $324M invested in Tvardi Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 70 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 178 → 164 (-14)
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Holders
164
Holding in Top 10
–
Calls
$1.89M
Puts
$1.01M
Top Buyers
| 1 | +$4.09M | |
| 2 | +$2.15M | |
| 3 | +$1.49M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$1.4M |
| 5 |
Morgan Stanley
New York
|
+$1.32M |
Top Sellers
| 1 | -$7.11M | |
| 2 | -$2.54M | |
| 3 | -$1.5M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.5M |
| 5 |
Two Sigma Investments
New York
|
-$1.24M |